ProteoNic, a specialist in advanced protein expression technology, has expanded its partnership with Abzena, the end-to-end integrated CDMO. Following the successful launch of AbZelectPRO, a high-producing cell line development platform that combines ProteoNic’s 2G UNic vector technology with Abzena’s host cell line, Abzena has decided to make this combined platform the standard offering for all of its customers.   Over the past 10 months, the integration of the 2G UNic technology with A...